Sign in to view content

Assessing Commercially Available Cell Therapies for Retinal Disease in the U.S.

Ajay E Kuriyan, MD, MS
Daniel Simhaee, MD

Video
Published 2018

Related

Episode 5: Adding Dexamethasone Implant to Ranibizumab for Persistent DME with Dr. Raj Maturi
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of Great Than or Equal to 4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S
Allen Chiang, MD, FASRS
Annual Meeting Talks
2019
Randomized Trial Comparing Pneumatic Retinopexy vs Vitrectomy
Rajeev H. Muni, MD, MSC, FRCS(C), FASRS
Updates from the Field
2017

Category: Hereditary Retinal Disease & Genetics

See more